Generic Loestrin 21 1.5/30 Availability
Last updated on May 7, 2025.
Loestrin 21 1.5/30 is a brand name of ethinyl estradiol/norethindrone, approved by the FDA in the following formulation(s):
LOESTRIN 21 1.5/30 (ethinyl estradiol; norethindrone acetate - tablet;oral-21)
-
Manufacturer: TEVA BRANDED PHARM
Approved Prior to Jan 1, 1982
Strength(s): 0.03MG;1.5MG (discontinued) [RLD]
All of the above formulations have been discontinued.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Loestrin 21 1.5/30. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Loestrin 21 1.5 / 30 (ethinyl estradiol / norethindrone)
- Loestrin 21 1.5/30 consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
Related treatment guides
Related/similar drugs
Provera
Provera is used for abnormal uterine bleeding, amenorrhea, birth control, endometrial cancer ...
Depo Provera
Depo-Provera is used as contraception to prevent pregnancy. It is also used to reduce pain cause by ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Mirena
Mirena (levonorgestrel) is a plastic intrauterine device placed in the uterus and is used to ...
Nexplanon
Nexplanon is a long-term, reversible birth control implant that lasts for three years. Learn about ...
Yaz
Yaz (drospirenone and ethinyl estradiol) is used as a contraceptive to prevent pregnancy. Includes ...
Slynd
Slynd (drospirenone) is a birth control pill used for the prevention of pregnancy. Includes Slynd ...
Sprintec
Sprintec is used for abnormal uterine bleeding, birth control, endometriosis, gonadotropin ...
Medroxyprogesterone
Medroxyprogesterone (Provera) treats conditions such as absent or irregular menstrual periods, or ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.